WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced that it will participate in two upcoming healthcare conferences in September to highlight corporate updates and its development strategy.
The company’s Chief Executive Officer, Dr. Neal Walker, along with senior leadership, will take part in a fireside chat during the Cantor Global Healthcare Conference on Wednesday, September 3, 2025, at 1:00 p.m. EDT in New York.
On Tuesday, September 9, 2025, at 9:00 a.m. EDT, Dr. Walker will also deliver a corporate presentation at the H.C. Wainwright 27th Annual Global Investment Conference, also in New York.
Live and archived webcasts of both events will be accessible through the company’s website and available for at least 30 days.
Aclaris Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for immuno-inflammatory diseases with limited treatment options.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.